Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Quality of Life × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Neoplasms 8 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Pain 2 Multiple Myeloma 2 Hematologic Neoplasms 2 Fatigue 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Weight Loss 1 Uterine Cervical Neoplasms 1 To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT 1 Thymus Neoplasms 1 Thrombocytopenia 1 Symptom Management 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Splenomegaly 1 Speech 1 Sexual Dysfunction, Physiological 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Synovial 1 Rectal Neoplasms 1 Quality of Life 1

Interventions

Temozolomide 99 Magnetic Resonance Spectroscopy 46 Bevacizumab 46 Radiotherapy 41 Irinotecan 23 Blood Specimen Collection 15 Aminolevulinic Acid 15 Surgical Procedures, Operative 13 Radiation 13 Carboplatin 13 Nivolumab 12 fluorodopa F 18 10 Radiotherapy, Intensity-Modulated 10 Radiosurgery 10 Carmustine 10 pembrolizumab 9 Topotecan 9 Surveys and Questionnaires 8 Specimen Handling 8 Magnetic Resonance Imaging 8 Erlotinib Hydrochloride 8 Biopsy 8 poly ICLC 7 Standard of Care 7 Filgrastim 7 Everolimus 7 Etoposide 7 Drug Therapy 7 Cyclophosphamide 7 ribociclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03257618 2026-03-12

TEMOIN

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡